Stock Talk · by Zeynep Demir · 2026-09-23

PFE feels like the classic value trap until I stare at the cash and pipeline again

I know the post-pandemic hangover story. I know revenue comps got weird and sentiment is terrible. Still, every time I dig in I end up thinking the market may be pricing it like nothing good ever happens again.

This is not a pound-the-table thesis. More like a 'do I really need excitement from my pharma allocation?' thesis.

1 sparks · 6 comments

Comments

Grace Parker · 13 likes

The issue is opportunity cost. Cheap can stay cheap while quality compounds somewhere else.

Kabir Khan · 6 likes

Pipeline reads better on paper than the chart does, that's for sure.

Zeynep Demir · 3 likes

Yep. That's the whole internal debate in one sentence.

Paper Sparrow · 1 likes

PFE is where people go when they want to feel prudent and slightly miserable.

Ruby Wilson · 1 likes

I nibbled for income and then had to explain to myself why I was suddenly a yield guy.

Mariana Costa · 0 likes

Sometimes the value trap label just means everyone wants a cleaner story.